NanoViricides, Inc. (NASDAQ:NNVC)

PRESS RELEASE

published on 03/04/2025 at 12:30, 1 year 6 months ago

Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan
HHS Secretary Robert F. Kennedy Jr. discusses urgent need for antiviral treatment in FoxNews Op-Ed amidst measles outbreak, highlighting potential of NanoViricides' NV-387 drug

Robert F. Kennedy Jr. Antiviral Treatment Measles Outbreak HHS Secretary NanoViricides NV-387
BRIEF

published on 02/19/2025 at 12:35, 1 year 7 months ago

NanoViricides Reports Q4 2024 Financials and NV-387 Clinical Trials Progress

NanoViricides NV-387 Clinical Trials Financial Reports Antiviral Development
BRIEF

published on 02/19/2025 at 12:35, 1 year 7 months ago

NanoViricides publie ses résultats financiers du quatrième trimestre 2024 et les progrès des essais cliniques sur le NV-387

NanoViricides NV-387 Essais Cliniques Rapports Financiers Développement D'antiviraux
PRESS RELEASE

published on 02/19/2025 at 12:30, 1 year 7 months ago

NanoViricides, Inc. Has Filed its Quarterly Report
NanoViricides, Inc. prepares for Phase II clinical trials of broad-spectrum antiviral NV-387, focused on MPox pandemic and Bird Flu, with strong financials and innovative drug strategy

NanoViricides NV-387 Phase II Trial Mpox Bird Flu
BRIEF

published on 02/11/2025 at 12:35, 1 year 7 months ago

NanoViricides Prepares for Bird Flu Fight with NV-387

NanoViricides NV-387 H5N1 Bird Flu Pandemic Preparedness
BRIEF

published on 02/11/2025 at 12:35, 1 year 7 months ago

NanoViricides se prépare à la lutte contre la grippe aviaire avec le NV-387

NanoViricides NV-387 H5N1 Grippe Aviaire Préparation À Une Pandémie
PRESS RELEASE

published on 02/11/2025 at 12:30, 1 year 7 months ago

NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape
NanoViricides, Inc. declares readiness to combat bird flu with broad-spectrum antiviral drug NV-387. Scientific discussion on virus mutations and potential effectiveness against H5N1. Focus on Trump administration's response

NV-387 NanoViricides Inc. Antiviral Drug H5N1 Bird Flu
BRIEF

published on 01/29/2025 at 12:35, 1 year 8 months ago

NanoViricides to Present at MicroCap Conference 2025

NanoViricides NV-387 Microcap Conference Clinical Trials Antiviral Drug
BRIEF

published on 01/29/2025 at 12:35, 1 year 8 months ago

NanoViricides sera présenté à la conférence MicroCap 2025

NanoViricides NV-387 Essais Cliniques Conférence MicroCap Médicament Antiviral
PRESS RELEASE

published on 01/29/2025 at 12:30, 1 year 8 months ago

NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025
NanoViricides, Inc. presents its groundbreaking broad-spectrum antiviral drug NV-387 at MicroCap Conference 2025, showing promising results against various viral infections

NanoViricides NV-387 Microcap Conference Antiviral Drug Viral Infections

Published on 09/29/2026 at 15:05, 1 hour 2 minutes ago

Banyan Gold Closes $54.3 Million Financing
Published on 09/29/2026 at 15:00, 1 hour 7 minutes ago

As Crisis Events Intensify, BlackBerry and the American Red Cross Renew Commitment to Secure and Trusted Emergency Communications
Published on 09/29/2026 at 14:45, 1 hour 22 minutes ago

NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Is In Phase II Clinical Trials
Published on 09/29/2026 at 14:30, 1 hour 37 minutes ago

Solitario Resources Presentation Change of Time at the 38th Annual Mining Forum Americas 2026 Conference
Published on 09/29/2026 at 14:30, 1 hour 37 minutes ago

Hillcrest ZVS Technology Demonstrates More Than 90% Reduction in Motor Voltage Spikes

View all ACCESSWIRE

Published on 09/29/2026 at 15:58, 9 minutes ago

mobilezone awarded EcoVadis Silver Medal for sustainability performance
Published on 09/29/2026 at 15:48, 18 minutes ago

Holding(s) in Company
Published on 09/29/2026 at 15:13, 54 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 09/29/2026 at 15:12, 54 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc
Published on 09/29/2026 at 15:11, 56 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc

View all EQS

Published on 09/29/2026 at 14:15, 1 hour 51 minutes ago

260929 BENETEAU Mise en oeuvre du programme de rachat d'actions
Published on 09/29/2026 at 12:15, 3 hours 51 minutes ago

NRJ GROUP - Affaire Fun Radio - Report du délibéré de la Cour d'appel
Published on 09/29/2026 at 08:45, 7 hours 22 minutes ago

Cegedim Santé réinvente l’accès à l’information médicale en déployant l’Assistant by Claude Bernard IA sur toutes ses solutions de médecine de ville
Published on 09/28/2026 at 17:54, 22 hours 12 minutes ago

Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:54, 22 hours 12 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026

View all LES ECHOS COMFI WIRE

News